ArticleThe oncologist2020

Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pancreatic Cancer.

Robert W Corty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.